Skip to content

Janus Living JAN Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$4.7M-2.8%
Gross profit$3.6M+85.6%
Operating income-$2.7M-41.0%
Net income-$271.5M-11,250%
EPS (diluted)-$2.14-1,327%

Balance sheet

See full
Cash & equivalents$10.5M-2.7%
Total debt$107.0K-99.4%
Total equity$889.7M+3,976%
Total assets$959.7M+1,130%

Cash flow

See full
Operating cash flow-$12.3M-764%
CapEx$2.8K
Free cash flow-$1.8M

Valuation

See full
Market cap$5.56B+43,568%
Enterprise value$5.55B+26,232%
P/S231.5×+231×

Profitability

See full
Gross margin46.5%+1.2pp
Operating margin-99.7%-717pp
Net margin-2,552.7%-2,601pp
FCF margin-29.7%

Returns & leverage

See full
Return on equity-134.6%-791pp
Debt / equity-0.5×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Janus Living in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Janus Living ’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janus Living 's finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Janus Living 's finite lived intangible assets - gross?
Janus Living (JAN) reported finite lived intangible assets - gross of $27.59M in Q1 2026.
How has Janus Living 's finite lived intangible assets - gross changed year-over-year?
Janus Living 's finite lived intangible assets - gross decreased by 29.8% year-over-year, from $39.28M to $27.59M.
What is the long-term trend for Janus Living 's finite lived intangible assets - gross?
Over 2 years (2023 to 2025), Janus Living 's finite lived intangible assets - gross has grown at a 19.7% compound annual growth rate (CAGR), from $19.3M to $27.66M.
What does finite lived intangible assets - gross mean?
This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.